Joints, muscles and pain
Boswellia serrataand Morning Stiffness Duration
Both sources here measured lower morning Stiffness Duration.
How sure anyone can be
Low certainty, level 2 of 4Further research is likely to change this.
The most certain of the two findings here; each record carries its own.
The numbers reported
One source’s range, drawn against its own line of no difference and scaled to its own numbers.
-15.86-10.04-4.22
This range stays on one side of the no-difference line.
Two sources, newest first
What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.
Systematic review, 2024
Low certainty, level 2 of 4Efficacy evaluation of standardized Boswellia serrata extract (Aflapin(Ⓡ)) in osteoarthritis: A systematic review and sub-group meta-analysis study.
Explore (NY). 2024;20(5):102983. doi:10.1016/j.explore.2024.02.001. PMID:38365549.
- Number reported
- -5.49
- Which way it went
- Lower
- Likely range
- Not in the abstract
- Source’s own words
- points on the WOMAC stiffness subscale, mean difference vs control
- Who was studied
- Adult with osteoarthritis
- Compared with
- control therapy
- Amount taken
- Not in the abstract
- For how long
- Not in the abstract
- Disagreement between studies
- Not in the abstract
- Kind of record
- Journal article
How this rating was reachedstarts at High, 2 steps down: indirectness and imprecision
- Starts at High
- Indirectness brought it down to Moderatethe outcome measured is a proxy for the target outcomeReported in the abstract
- Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
- Ends at Low2 steps down.
- Checked, nothing to step it down for
- risk of bias
- Inconsistency
- No disagreement reported, and no count of studies behind it
Imprecision stops at the first check that applies; others may apply too.
Source saved; quote checked byte-for-byte against it by software; no signature.
Systematic review, 2020
Very low certainty, level 1 of 4Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis.
BMC Complement Med Ther. 2020;20(1):225. doi:10.1186/s12906-020-02985-6. PMID:32680575.
- Number reported
- -10.04
- Which way it went
- Lower
- Likely range
- -15.86 to -4.22
- Source’s own words
- points on the WOMAC stiffness subscale, weighted mean difference vs control
- Who was studied
- Adult with osteoarthritis
- Compared with
- placebo or western medicine
- Amount taken
- Not in the abstract
- For how long
- Not in the abstract
- Disagreement between studies
- Not in the abstract
- Kind of record
- Journal article
How this rating was reachedstarts at High, 3 steps down: risk of bias, indirectness and imprecision
- Starts at High
- Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
- Indirectness brought it down to Lowthe outcome measured is a proxy for the target outcomeReported in the abstract
- Imprecision brought it down to Very lowthe abstract does not state how many participants were pooledNot in the abstract
- Ends at Very low3 steps down.
- Inconsistency
- No disagreement reported, and no count of studies behind it
Imprecision stops at the first check that applies; others may apply too.
AI review could not confirm it — an AI agent re-read this finding against the saved source and at least one check failed. The batch record names the check and quotes the sentence that caused the doubt. No person read it.
What is still missing from these readings
- One gives no likely range, so how precise that number is is unknown.
- Two do not say how many people took part.
- Amount taken — Not in the abstract.
- For how long — Not in the abstract.
Something nobody wrote down is never a zero and never a guess.
Still to read for Boswellia serrata
Eight of the 13 things on our list for Boswellia serrata have no reading here yet:
- Alanine aminotransferase (ALT)
- Equivalent Walking Distance
- Erythrocyte Sedimentation Rate (ESR)
- Forced Vital Capacity (FVC)
- Hemoglobin
- Peak Expiratory Flow Rate
- Physical Function Score (SF-36 Physical Functioning)
- Serum creatinine
Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.
Read next
Boswellia serrata
Four other questions read for it
Joints, muscles and pain
18 questions read under it
Morning Stiffness Duration
No other ingredients read against it
Alphabetical, and by nothing else.
This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.